Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.


CSE:RVV - Post by User

Revive Therapeutics Ltd.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(726)
•••
Post by mrnormalon Sep 28, 2020 4:54pm
274 Views
Post# 31631514

Shroom Boom Volume

Shroom Boom Volume

Has arrived. Lots of chatter over the weekend as Revive is in a great Shroom, Psychedelics therapy position.

Lot of interest in the Oral Fast Dissolving Film

Proprietary oral fast-dissolving drug delivery system, fast psilocin, rapidly releases an expansive list of pharmaceuticals, emulsified psilocybin

This permits API’s to enter the bloodstream through a fast dose pathway without being degraded or modified by first pass metabolism in the liver.

Sublingual and transmucosal transport of active molecules result from the rapid dissolution of Fast Strips combined with the proprietary technology

https://www.psilocinpharma.com/pipeline.html

https://www.youtube.com/watch?v=0QrPCHW-fPA

https://www.psilocinpharma.com/

https://www.youtube.com/watch?v=PhJkrEgjgxg
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities